once-weekly semaglutide in persons with obesity and knee osteoarthritis "Among participants with obesity and knee osteoarthritis with moderate-to-severe pain, treatment with once-weekly injectable semaglutide resulted in significantly greater Once-Weekly Semaglutide in Persons with

Polycystic ovary syndrome and reproductive health: a comprehensive review

The #uncomfortable #truth This 2026 BMJ systematic review and #metaanalysis delivers one of the clearest reality checks yet on weight regain after stopping weight-management medications (WMMs), including GLP-1 and dual incretin therapies

Most headaches associated with GLP-1 weight loss injections are mild to moderate and tend to occur during the initial weeks of treatment or following dose escalation

Possibly, but with extra caution

The marketplace quality gap Without identifying specific sellers, community quality reports describe a consistent pattern in marketplace-sourced bacteriostatic water